相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up
Erik Ahlstrand et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival
Vincenzo Accurso et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2020)
Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Vera with Cardiovascular Risk Factors?
Salvatrice Mancuso et al.
ONCOLOGY RESEARCH AND TREATMENT (2020)
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy
Naveen Pemmaraju et al.
BLOOD (2019)
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
Natasha Szuber et al.
MAYO CLINIC PROCEEDINGS (2019)
Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values
Richard T. Silver et al.
HAEMATOLOGICA (2019)
Comparison between thrombotic risk scores in essential thrombocythemia and survival implications
M. Santoro et al.
HEMATOLOGICAL ONCOLOGY (2019)
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms A Population-Based Cohort Study
Malin Hultcrantz et al.
ANNALS OF INTERNAL MEDICINE (2018)
Dysregulated iron metabolism in polycythemia vera: etiology and consequences
Yelena Z. Ginzburg et al.
LEUKEMIA (2018)
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
Elisa Rumi et al.
BLOOD (2017)
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients
S. Cerquozzi et al.
BLOOD CANCER JOURNAL (2017)
A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera
Anneli Enblom-Larsson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera - single center experience
Lucia Masarova et al.
LEUKEMIA & LYMPHOMA (2016)
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients
Alessandro Andriani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey
Ruben Mesa et al.
BMC CANCER (2016)
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia
Veronika Buxhofer-Ausch et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
The Prevalence of Anemia and Moderate-Severe Anemia in the US Population (NHANES 2003-2012)
Chi Huu Hong Le
PLOS ONE (2016)
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
Alessandro M. Vannucchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms
Martyna Borowczyk et al.
THROMBOSIS RESEARCH (2015)
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients
Marco Montanaro et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology
Tiziano Barbui et al.
BLOOD (2014)
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi et al.
BLOOD (2014)
Survival Patterns in United States (US) Medicare Enrollees with Non-CML Myeloproliferative Neoplasms (MPN)
Gregory L. Price et al.
PLOS ONE (2014)
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A. Tefferi et al.
LEUKEMIA (2013)
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
Francesco Passamonti et al.
BLOOD (2012)
Very elderly patients with essential thrombocythaemia: are they a separate category? A monocentric study on 118 patients older than 75 years
Francesca Palandri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
Robyn M. Emanuel et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
Malin Hultcrantz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study
Francesca Palandri et al.
ANNALS OF HEMATOLOGY (2011)
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
Alessandra Carobbio et al.
BLOOD (2011)
Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events
Vanesa Caruso et al.
BLOOD (2010)
JAK2V617F allele burden and thrombosis: A direct comparison in essential thrombocythemia and polycythemia vera
Alessandra Carobbio et al.
EXPERIMENTAL HEMATOLOGY (2009)
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
Valerio De Stefano et al.
HAEMATOLOGICA (2008)
Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation
Naseema Gangat et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera
R Marchioli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
MA Elliott et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
F Passamonti et al.
AMERICAN JOURNAL OF MEDICINE (2004)
分享论文
